These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT. Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe S; French P; Hutton P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TR; Davies L; Shields G; Buck D; Tully S; Kingdon D Health Technol Assess; 2019 Feb; 23(7):1-144. PubMed ID: 30806619 [TBL] [Abstract][Full Text] [Related]
3. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study. Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A; Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925 [TBL] [Abstract][Full Text] [Related]
4. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study. Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187 [TBL] [Abstract][Full Text] [Related]
5. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T; Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688 [TBL] [Abstract][Full Text] [Related]
6. Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trial. Pyle M; Norrie J; Schwannauer M; Kingdon D; Gumley A; Turkington D; Byrne R; Syrett S; MacLennan G; Dudley R; McLeod HJ; Griffiths H; Bowe S; Barnes TR; French P; Hutton P; Davies L; Morrison AP BMC Psychiatry; 2016 Aug; 16():280. PubMed ID: 27496180 [TBL] [Abstract][Full Text] [Related]
7. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial. Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240 [TBL] [Abstract][Full Text] [Related]
8. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Morrison AP; Turkington D; Pyle M; Spencer H; Brabban A; Dunn G; Christodoulides T; Dudley R; Chapman N; Callcott P; Grace T; Lumley V; Drage L; Tully S; Irving K; Cummings A; Byrne R; Davies LM; Hutton P Lancet; 2014 Apr; 383(9926):1395-403. PubMed ID: 24508320 [TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074 [TBL] [Abstract][Full Text] [Related]
10. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial. Everitt HA; Landau S; O'Reilly G; Sibelli A; Hughes S; Windgassen S; Holland R; Little P; McCrone P; Bishop FL; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):863-872. PubMed ID: 31492643 [TBL] [Abstract][Full Text] [Related]
11. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness. Barnes TR; Leeson VC; Paton C; Marston L; Davies L; Whittaker W; Osborn D; Kumar R; Keown P; Zafar R; Iqbal K; Singh V; Fridrich P; Fitzgerald Z; Bagalkote H; Haddad PM; Husni M; Amos T Health Technol Assess; 2017 Sep; 21(49):1-56. PubMed ID: 28869006 [TBL] [Abstract][Full Text] [Related]
12. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis. Freeman D; Dunn G; Startup H; Pugh K; Cordwell J; Mander H; Černis E; Wingham G; Shirvell K; Kingdon D Lancet Psychiatry; 2015 Apr; 2(4):305-13. PubMed ID: 26360083 [TBL] [Abstract][Full Text] [Related]
13. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Wiles N; Thomas L; Abel A; Ridgway N; Turner N; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G Lancet; 2013 Feb; 381(9864):375-84. PubMed ID: 23219570 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial. Freeman D; Waite F; Startup H; Myers E; Lister R; McInerney J; Harvey AG; Geddes J; Zaiwalla Z; Luengo-Fernandez R; Foster R; Clifton L; Yu LM Lancet Psychiatry; 2015 Nov; 2(11):975-83. PubMed ID: 26363701 [TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia. Melzer-Ribeiro DL; Napolitano IC; Leite SA; Alencar de Souza JA; Vizzotto ADB; Di Sarno ES; Fortes M; Gomes ML; de Oliveira GM; Avrichir BS; Talib LL; Correll CU; Elkis H Schizophr Res; 2024 Jun; 268():252-260. PubMed ID: 38151432 [TBL] [Abstract][Full Text] [Related]
16. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. O'Dowd H; Gladwell P; Rogers CA; Hollinghurst S; Gregory A Health Technol Assess; 2006 Oct; 10(37):iii-iv, ix-x, 1-121. PubMed ID: 17014748 [TBL] [Abstract][Full Text] [Related]
17. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial. Safren SA; Bedoya CA; O'Cleirigh C; Biello KB; Pinkston MM; Stein MD; Traeger L; Kojic E; Robbins GK; Lerner JA; Herman DS; Mimiaga MJ; Mayer KH Lancet HIV; 2016 Nov; 3(11):e529-e538. PubMed ID: 27658881 [TBL] [Abstract][Full Text] [Related]
18. Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial. Goodyer IM; Reynolds S; Barrett B; Byford S; Dubicka B; Hill J; Holland F; Kelvin R; Midgley N; Roberts C; Senior R; Target M; Widmer B; Wilkinson P; Fonagy P Health Technol Assess; 2017 Mar; 21(12):1-94. PubMed ID: 28394249 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial. Chatterjee S; Naik S; John S; Dabholkar H; Balaji M; Koschorke M; Varghese M; Thara R; Weiss HA; Williams P; McCrone P; Patel V; Thornicroft G Lancet; 2014 Apr; 383(9926):1385-94. PubMed ID: 24612754 [TBL] [Abstract][Full Text] [Related]
20. CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis. Todorovic A; Lal S; Dark F; De Monte V; Kisely S; Siskind D J Ment Health; 2023 Feb; 32(1):321-328. PubMed ID: 33076721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]